Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 1294 entries
View as:

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

Phase: N/A Priority: Normal
NCT ID: NCT00184691 Org: User:
Start: 04/30/99 End: 06/30/05 Due: 06/30/06

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01059799 Org: User:
Start: 02/01/10 End: 12/16/10 Due: 12/16/11

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Phase: N/A Priority: Normal
NCT ID: NCT04334057 Org: User:
Start: 03/31/21 End: 11/30/23 Due: 11/30/24

Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02172313 Org: User:
Start: 06/30/14 End: 10/31/14 Due: 10/31/15

A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists

Phase: N/A Priority: Normal
NCT ID: NCT05755373 Org: User:
Start: 03/24/23 End: 05/15/23 Due: 05/15/24

Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants

Phase: N/A Priority: Normal
NCT ID: NCT02608853 Org: User:
Start: 01/31/15 End: 01/31/15 Due: 01/31/16

A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02230631 Org: User:
Start: 10/31/14 End: 03/31/15 Due: 03/31/16

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01079234 Org: User:
Start: 03/31/10 End: 05/31/11 Due: 05/31/12

Safety of NNC 0123-0000-0338 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01334034 Org: User:
Start: 04/11/11 End: 09/16/11 Due: 09/16/12

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

Phase: N/A Priority: Normal
NCT ID: NCT03856047 Org: User:
Start: 03/01/19 End: 03/25/21 Due: 03/25/22

Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01865292 Org: User:
Start: 08/31/06 End: 11/30/06 Due: 11/30/07

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03086330 Org: User:
Start: 03/15/17 End: 08/06/18 Due: 08/06/19

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT06979375 Org: User:
Start: 07/01/25 End: 01/23/28 Due: 01/23/29

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT06979362 Org: User:
Start: 07/01/25 End: 01/23/28 Due: 01/23/29

Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01720290 Org: User:
Start: 07/25/02 End: 02/25/03 Due: 02/25/04

A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02773368 Org: User:
Start: 05/23/16 End: 10/23/17 Due: 10/23/18

Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)

Phase: N/A Priority: Normal
NCT ID: NCT00657930 Org: User:
Start: 03/31/08 End: 04/30/09 Due: 04/30/10

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Phase: N/A Priority: Normal
NCT ID: NCT01766245 Org: User:
Start: 12/31/12 End: 05/31/13 Due: 05/31/14

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01511692 Org: User:
Start: 11/30/05 End: 09/30/07 Due: 09/30/08

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Phase: N/A Priority: Normal
NCT ID: NCT03797885 Org: User:
Start: 01/15/19 End: 10/15/19 Due: 10/15/20

A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06478550 Org: User:
Start: 06/26/24 End: 04/23/25 Due: 04/23/26

A Study Collecting Remote Data in People With an Overweight Condition or Obesity on a Weight Management Program

Phase: N/A Priority: Normal
NCT ID: NCT06805539 Org: User:
Start: 04/14/25 End: 04/30/26 Due: 04/30/27

A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02670213 Org: User:
Start: 03/16/16 End: 09/30/24 Due: 09/30/25

Adverse Event Data Collection From External Registries on Nonacog Beta Pegol

Phase: N/A Priority: Normal
NCT ID: NCT03690336 Org: User:
Start: 10/01/18 End: 10/01/27 Due: 10/01/28

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia

Phase: N/A Priority: Normal
NCT ID: NCT01934686 Org: User:
Start: 09/30/13 End: 03/31/14 Due: 03/31/15